Rivastigmine經皮吸收貼片的全球市場(2022年～2028年)

Rivastigmine Transdermal Patches Market 2022-2028

出版日期: 2022年09月22日 | 出版商:

Orion Market Research | 英文 125 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

全球Rivastigmine經皮吸收貼片的市場規模在預測期間內預計將以6.5％的年複合成長率成長。推動市場成長的主要因素有其用於治療與帕金森病和阿爾茨海默病相關的癡呆症、與其他給藥途徑相比的顯著優勢、低成本和藥物依從性。例如，它對患者較少的患者很方便等。

本報告提供全球Rivastigmine經皮吸收貼片市場調查，提供市場概要，市場的推動因素與阻礙因素的分析，市場機會，各市場區隔，各地區的市場分析，主要企業的簡介等系統性資訊。

The global rivastigmine transdermal patches market is anticipated to grow at a CAGR of 6.5% during the forecast period. Rivastigmine transdermal patches are used for the treatment of dementia-related to Parkinson's disease and Alzheimer's diseases with mild, moderate, and severe symptoms. Innovations in transdermal delivery systems contributed to medical practice by providing advances in the delivery of treatment with existing and novel drugs. Transdermal delivery systems have significant advantages over other routes of administration. It is used as a non-invasive, painless technique allowing less frequent or one-time dosing application in comparison to oral and other routes of administration. It reduces the gastrointestinal side-effects, enhances the therapeutic efficacy, and avoids the problem associated with a drug's toxicity, and drug formulation problems. Further, the rivastigmine transdermal patches are inexpensive and convenient for patients with fewer adherences to medications as it allows the maintenance of drug plasma levels due to consistent infusion and bioavailability of the drug. All these factors are driving the global rivastigmine transdermal patches market. Further, the continuous innovation and launches of rivastigmine transdermal patches are anticipated to boost market growth. For instance, in March 2019, Amneal Pharmaceuticals announced that it has launched its generic version of the rivastigmine transdermal system, 4.6 mg/24 hours, 9.5 mg/24 hours, and 13.3 mg/24 hours. The Company received FDA approval for its rivastigmine transdermal System in January 2019.

The global rivastigmine transdermal patches market is segmented based on the type and application. Based on the type, the market is segmented into 4.6mg/24hr, 9.5mg/24hr, and 13.3 mg/24hr. Based on the application, the market is segmented into Alzheimer's disease, Parkinson's disease, and others. Based on type 9.5mg/24hr segment is anticipated to hold the dominant share in the market during the forecast period. High adherence to medication in patients, fewer side effects, and high efficacy of the medicine is the prime factor for the growth of the segment in the market.

Geographically, the market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America holds the dominant share in the market due to the existence of key companies in the region. Growing R&D and the launch of innovative techniques to deliver medicine are factors driving the market in the region. However, the Asia-Pacific region is anticipated to register the highest growth in the market during the forecast period owing to the expansion of pharmaceutical companies and awareness about neurological diseases among the population are some key factors driving the market in the region.

The major companies serving the global rivastigmine transdermal patches market include Amneal Pharmaceuticals Inc., Luye Pharma Group, Novartis International AG, Ono Pharmaceutical Co., Ltd., and Zydus Healthcare Ltd. The market players are contributing to the market growth by the adoption of various strategies including mergers and acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in May 2021, Luye Pharma Group announced the successful completion of the Decentralized Registration Procedures (DCPs) for its Rivastigmine Multi-Day Transdermal Patch (Rivastigmine MD).

Research Methodology

The market study of the global rivastigmine transdermal patches market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market into various segments, and derive the total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include:

Financial reports of companies involved in the market.
Whitepapers, research papers, and news blogs.
Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. Global Rivastigmine Transdermal Patches Market Research and Analysis by Type

2. Global Rivastigmine Transdermal Patches Market Research and Analysis by Application

The Report Covers:

Comprehensive Research Methodology of the global rivastigmine transdermal patches market.
This report also includes a detailed and extensive market overview with key analyst insights.
An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
Analysis of regional regulations and other government policies impacting the global rivastigmine transdermal patches market.
Insights about market determinants that are stimulating the global rivastigmine transdermal patches market.
Detailed and extensive market segments with the regional distribution of forecasted revenues.
Extensive profiles and recent developments of market players.

1. Report Summary

Current Industry Analysis and Growth Potential Outlook
1.1. Research Methods and Tools
1.2. Market Breakdown
- 1.2.1. By Segments
- 1.2.2. By Region

2. Market Overview and Insights

2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
- 2.2.1. Key Findings
- 2.2.2. Recommendations
- 2.2.3. Conclusion

3. Competitive Landscape

3.1. Key Company Analysis
- 3.1.1. Amneal Pharmaceuticals Inc.
  - 3.1.1.1. Overview
  - 3.1.1.2. Financial Analysis
  - 3.1.1.3. SWOT Analysis
  - 3.1.1.4. Recent Developments
- 3.1.2. Luye Pharma Group
  - 3.1.2.1. Overview
  - 3.1.2.2. Financial Analysis
  - 3.1.2.3. SWOT Analysis
  - 3.1.2.4. Recent Developments
- 3.1.3. Novartis International AG
  - 3.1.3.1. Overview
  - 3.1.3.2. Financial Analysis
  - 3.1.3.3. SWOT Analysis
  - 3.1.3.4. Recent Developments
- 3.1.4. Ono Pharmaceutical Co., Ltd.
  - 3.1.4.1. Overview
  - 3.1.4.2. Financial Analysis
  - 3.1.4.3. SWOT Analysis
  - 3.1.4.4. Recent Developments
- 3.1.5. Zydus Healthcare Ltd.
  - 3.1.5.1. Overview
  - 3.1.5.2. Financial Analysis
  - 3.1.5.3. SWOT Analysis
  - 3.1.5.4. Recent Developments
3.2. Key Strategy Analysis

4. Market Segmentation

4.1. Global Rivastigmine Transdermal Patches Market by Type
- 4.1.1. 4.6mg/24hr
- 4.1.2. 9.5mg/24hr
- 4.1.3. 13.3 mg/24hr
4.2. Global Rivastigmine Transdermal Patches Market by Application
- 4.2.1. Alzheimer's Disease
- 4.2.2. Parkinson's Disease
- 4.2.3. Others

5. Regional Analysis

5.1. North America
- 5.1.1. United States
- 5.1.2. Canada
5.2. Europe
- 5.2.1. UK
- 5.2.2. Germany
- 5.2.3. Italy
- 5.2.4. Spain
- 5.2.5. France
- 5.2.6. Rest of Europe
5.3. Asia-Pacific
- 5.3.1. China
- 5.3.2. India
- 5.3.3. Japan
- 5.3.4. South Korea
- 5.3.5. Rest of Asia-Pacific
5.4. Rest of the World

6. Company Profiles

6.1. AbbVie Inc.
6.2. Acino International AG
6.3. Alvogen
6.4. Amneal Pharmaceuticals LLC.
6.5. Mylan N.V.
6.6. NorthStar Rx LLC
6.7. SinSin Pharmaceutical Co., Ltd.
6.8. Sparsha Pharma International Pvt Ltd.

簡介目錄圖表

LIST OF TABLES

1. GLOBAL RIVASTIGMINE TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
2. GLOBAL RIVASTIGMINE TRANSDERMAL PATCHES FOR 4.6MG/24HR MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
3. GLOBAL RIVASTIGMINE TRANSDERMAL PATCHES FOR 9.5MG/24HR MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
4. GLOBAL RIVASTIGMINE TRANSDERMAL PATCHES FOR 13.3 MG/24HR MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
5. GLOBAL RIVASTIGMINE TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
6. GLOBAL RIVASTIGMINE TRANSDERMAL PATCHES FOR ALZHEIMER'S DISEASE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
7. GLOBAL RIVASTIGMINE TRANSDERMAL PATCHES FOR PARKINSON'S DISEASE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
8. GLOBAL RIVASTIGMINE TRANSDERMAL PATCHES FOR OTHER APPLICATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
9. GLOBAL RIVASTIGMINE TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
10. NORTH AMERICAN RIVASTIGMINE TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
11. NORTH AMERICAN RIVASTIGMINE TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
12. NORTH AMERICAN RIVASTIGMINE TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
13. EUROPEAN RIVASTIGMINE TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
14. EUROPEAN RIVASTIGMINE TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
15. EUROPEAN RIVASTIGMINE TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
16. ASIA-PACIFIC RIVASTIGMINE TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
17. ASIA-PACIFIC RIVASTIGMINE TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
18. ASIA-PACIFIC RIVASTIGMINE TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
19. REST OF THE WORLD RIVASTIGMINE TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
20. REST OF THE WORLD RIVASTIGMINE TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
21. REST OF THE WORLD RIVASTIGMINE TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)

LIST OF FIGURES

1. GLOBAL RIVASTIGMINE TRANSDERMAL PATCHES MARKET SHARE BY TYPE, 2021 VS 2028 (%)
2. GLOBAL RIVASTIGMINE TRANSDERMAL PATCHES FOR 4.6MG/24HR MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
3. GLOBAL RIVASTIGMINE TRANSDERMAL PATCHES FOR 9.5MG/24HR MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
4. GLOBAL RIVASTIGMINE TRANSDERMAL PATCHES FOR 13.3 MG/24HR MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
5. GLOBAL RIVASTIGMINE TRANSDERMAL PATCHES MARKET SHARE BY APPLICATION, 2021 VS 2028 (%)
6. GLOBAL RIVASTIGMINE TRANSDERMAL PATCHES FOR ALZHEIMER'S DISEASE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
7. GLOBAL RIVASTIGMINE TRANSDERMAL PATCHES FOR PARKINSON'S DISEASE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
8. GLOBAL RIVASTIGMINE TRANSDERMAL PATCHES FOR OTHER APPLICATIONS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
9. GLOBAL RIVASTIGMINE TRANSDERMAL PATCHES MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
10. US RIVASTIGMINE TRANSDERMAL PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
11. CANADA RIVASTIGMINE TRANSDERMAL PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
12. UK RIVASTIGMINE TRANSDERMAL PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
13. FRANCE RIVASTIGMINE TRANSDERMAL PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
14. GERMANY RIVASTIGMINE TRANSDERMAL PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
15. ITALY RIVASTIGMINE TRANSDERMAL PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
16. SPAIN RIVASTIGMINE TRANSDERMAL PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
17. REST OF EUROPE RIVASTIGMINE TRANSDERMAL PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
18. INDIA RIVASTIGMINE TRANSDERMAL PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
19. CHINA RIVASTIGMINE TRANSDERMAL PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
20. JAPAN RIVASTIGMINE TRANSDERMAL PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
21. SOUTH KOREA RIVASTIGMINE TRANSDERMAL PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
22. REST OF ASIA-PACIFIC RIVASTIGMINE TRANSDERMAL PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
23. REST OF THE WORLD RIVASTIGMINE TRANSDERMAL PATCHES MARKET SIZE, 2021-2028 ($ MILLION)